Compare CNTB & IPEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNTB | IPEX |
|---|---|---|
| Founded | 2012 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 128.6M | 123.1M |
| IPO Year | 2021 | 2025 |
| Metric | CNTB | IPEX |
|---|---|---|
| Price | $2.57 | $10.35 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 94.0K | 14.6K |
| Earning Date | 03-31-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | ★ $762,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $24,739.01 | N/A |
| P/E Ratio | ★ N/A | $41.18 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.51 | $9.86 |
| 52 Week High | $3.28 | $10.40 |
| Indicator | CNTB | IPEX |
|---|---|---|
| Relative Strength Index (RSI) | 54.22 | 45.49 |
| Support Level | $2.23 | $10.30 |
| Resistance Level | $2.70 | $10.35 |
| Average True Range (ATR) | 0.24 | 0.04 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 70.18 | 37.50 |
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
Inflection Point Acquisition Corp V is a blank check company.